On Tuesday, August 30th, 2022, instrumentation in the core clinical laboratory will be undergoing required maintenance from approximately 08:00-14:00. This will delay resulting of the following assays in that time window:

Alpha 1 Antitrypsin [LAB927]
Amikacin drug level [LAB555]
Beta 2 Microglobulin [LAB49]
Bile Acids, Total [LAB2713]
C3 Complement [LAB152]
C4 Complement [LAB151]
Carbamazepine drug level [LAB22]
Cardiac CRP [LAB150]
Ceruloplasmin [LAB582]
Ethylene glycol, rapid assay [LAB7453]
Everolimus drug level [LAB7456]
Haptoglobin [LAB89]
Homocysteine [LAB93]
Keppra (levetiracetam) drug level [LAB477]
Lamotrigine (Lamictal) drug level (LAB475]
Lidocaine drug level [LAB641]
Pentobarbital drug level [LAB656]
Phenobarbital drug level [LAB30]
Phenytoin free drug level [LAB32]
Phenytoin drug level [LAB31]
Rheumatoid factor [LAB206]
Theophylline drug level [LAB35]
Tobramycin drug level [LAB36]
Valproic acid drug level [LAB25]

Questions should be directed to Matthew Krasowski, MD, PhD, medical director of the Clinical Chemistry (384-9380, matthew-krasowski@uiowa.edu).